Tenon Medical, Inc. (TNON) - Form 8-K Summary
Business Context and Reporting Period
Tenon Medical, Inc., a Delaware corporation and Emerging Growth Company, filed this Current Report on Form 8-K on February 5, 2026. The filing announces preliminary unaudited financial results for the fourth quarter and full fiscal year 2025, with the official earnings release and conference call scheduled for March 19, 2026.
Key Financial Metrics
| Metric | Period | Value |
|---|---|---|
| Revenue | Q4 2025 (Unaudited) | $1.45 million to $1.48 million |
| Revenue | Full Year 2025 (Unaudited) | $3.91 million to $3.94 million |
| Profit, Cash Flow, Margins, Debt, Liquidity | All Periods | Not provided in this filing |
Material Changes vs. Prior Period
- Q4 2025 vs. Q4 2024: Revenue increased by approximately 90% year-over-year.
- Full Year 2025 vs. Full Year 2024: Revenue increased by approximately 20% year-over-year.
Guidance, Outlook, and Management Commentary
Management has scheduled the release of detailed financial results for the fourth quarter and full year 2025 for March 19, 2026, following the market close. A conference call to discuss these results is set for 4:30 p.m. Eastern Time on the same day. The filing does not contain specific forward-looking guidance, risk factors, or details on contingencies beyond the standard disclosure that the press release is furnished and not "filed" for liability purposes.
Investor Verification Checklist
- Verify the final audited revenue figures against the preliminary range of $1.45M-$1.48M for Q4 2025 upon the March 19, 2026 release.
- Review the upcoming earnings call for details on gross margins, operating expenses, and cash burn rate, which are absent from this 8-K.
- Confirm the company's liquidity position and debt obligations in the upcoming 10-K or 10-Q filings.
- Monitor the stock price reaction to the 90% Q4 revenue growth announcement.